Literature DB >> 3312634

Expression of hepatitis B virus middle and large surface antigen genes in Saccharomyces cerevisiae.

T Imamura1, M Araki, A Miyanohara, J Nakao, H Yonemura, N Ohtomo, K Matsubara.   

Abstract

The hepatitis B virus genome carries the surface antigen (SAg) gene and an open reading frame that encodes two SAg-related polypeptides: SAg with a 55-amino-acid N-terminal extension polypeptide and SAg with a 174-amino-acid N-terminal extension polypeptide. These are termed middle S and large S, respectively. These polypeptides or their glycosylated derivatives have been detected in Dane particles, but their chemical and biological properties have remained largely unknown because of their limited availability. We attempted to produce these proteins in Saccharomyces cerevisiae by placing the coding regions under the control of the promoter of the yeast glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene. Yeast cells carrying middle S and large S coding sequences produced 33,000- and 42,000-dalton products, respectively, each of which reacted with anti-S antibody and bound to polymerized human serum albumin, in accordance with the known properties of pre-S proteins from particles in human sera (K. H. Heermann, U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich, J. Virol. 52:396-402, 1984; A. Machida, S. Kishimoto, H. Ohnuma, K. Baba, Y. Ito, H. Miyamoto, G. Funatsu, K. Oda, S. Usuda, S. Togami, T. Nakamura, Y. Miyakawa, and M. Mayumi, Gastroenterology 86:910-918, 1984). The middle S polypeptide is glycosylated and can be assembled into particles whose size and density are similar to those of SAg. However, this polypeptide was highly susceptible to proteolytic degradation into 29,000- and 26,000-dalton polypeptides, of which only the former retained the binding activity to polymerized albumin. The large S polypeptides are nonglycosylated, relatively stable, and do not seem to assemble into particles by themselves.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312634      PMCID: PMC255953          DOI: 10.1128/JVI.61.11.3543-3549.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322.

Authors:  C J Burrell; P Mackay; P J Greenaway; P H Hofschneider; K Murray
Journal:  Nature       Date:  1979-05-03       Impact factor: 49.962

3.  Cloning in Escherichia coli and physical structure of hepatitis B virion DNA.

Authors:  P Charnay; C Pourcel; A Louise; A Fritsch; P Tiollais
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

4.  Cloning and endonuclease mapping of the hepatitis B viral genome.

Authors:  J J Sninsky; A Siddiqui; W S Robinson; S N Cohen
Journal:  Nature       Date:  1979-05-24       Impact factor: 49.962

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen.

Authors:  P Valenzuela; P Gray; M Quiroga; J Zaldivar; H M Goodman; W J Rutter
Journal:  Nature       Date:  1979-08-30       Impact factor: 49.962

7.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

8.  Transformation of yeast.

Authors:  A Hinnen; J B Hicks; G R Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

9.  In vitro synthesis of repressible yeast acid phosphatase: identification of multiple mRNAs and products.

Authors:  K A Bostian; J M Lemire; L E Cannon; H O Halvorson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Selective synthesis and secretion of particles composed of the hepatitis B virus middle surface protein directed by a recombinant vaccinia virus: induction of antibodies to pre-S and S epitopes.

Authors:  K C Cheng; B Moss
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

View more
  8 in total

Review 1.  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.

Authors:  Wolfram H Gerlich
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

2.  Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants.

Authors:  Xiao-Ming Lou; Quan-Hong Yao; Zhen Zhang; Ri-He Peng; Ai-Sheng Xiong; Hua-Kun Wang
Journal:  Clin Vaccine Immunol       Date:  2007-02-21

3.  Saccharomyces cerevisiae can release hepatitis B virus surface antigen (HBsAg) particles into the medium by its secretory apparatus.

Authors:  S Kuroda; T Miyazaki; S Otaka; Y Fujisawa
Journal:  Appl Microbiol Biotechnol       Date:  1993-11       Impact factor: 4.813

4.  Expression of the core antigen gene of hepatitis B virus (HBV) in Acetobacter methanolicus using broad-host-range vectors.

Authors:  R Schröder; A Maassen; A Lippoldt; T Börner; R von Baehr; P Dobrowolski
Journal:  Appl Microbiol Biotechnol       Date:  1991-08       Impact factor: 4.813

5.  Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation.

Authors:  Tomasz Pniewski; Józef Kapusta; Piotr Bociąg; Anna Kostrzak; Olga Fedorowicz-Strońska; Marcin Czyż; Michał Gdula; Paweł Krajewski; Bogdan Wolko; Andrzej Płucienniczak
Journal:  Plant Cell Rep       Date:  2012-01-14       Impact factor: 4.570

6.  Exposition of hepatitis B surface antigen (HBsAg) on the surface of HEK293T cell and evaluation of its expression.

Authors:  Mina Mirian; Razieh Taghizadeh; Hossein Khanahmad; Mansour Salehi; Ali Jahanian-Najafabadi; Hojjat Sadeghi-Aliabadi; Shirin Kouhpayeh
Journal:  Res Pharm Sci       Date:  2016-10

Review 7.  Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections.

Authors:  Magdalena Figlerowicz; Magdalena Alejska; Anna Kurzyńska-Kokorniak; Marek Figlerowicz
Journal:  Med Res Rev       Date:  2003-07       Impact factor: 12.944

Review 8.  The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?

Authors:  Tomasz Pniewski
Journal:  Int J Mol Sci       Date:  2013-01-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.